To explore the possible molecular mechanisms underlying G2/M phase arrest in response to PCB treatment, the protein expression levels of Cdc2, cyclinB1, cyclinA2, cyclinE1, and cyclinD1 in BC cells were measured. The gene discussed is CCND1; the disease is breast cancer.